Clinical, biochemical, and histopathological diagnosis of Egyptian paediatric patients with suspected mitochondrial diseases: A hospital‑based study
Article Sidebar
Main Article Content
Abstract
Background. Mitochondrial respiratory chain (RC) disorders are a growing group of disorders with a large variety of clinical presentations ranging from well-defined clinical syndromes to nonspecific manifestations, such as failure to thrive, exercise intolerance and seizures.
Objective. To describe the clinical, biochemical, and histochemical spectrum of 38 Egyptian patients clinically suspected of having
mitochondrial RC disorders.
Methods. A total of 38 patients (female, n=18 (47.4%); male, n=20 (52.6%)) clinically suspected of having mitochondrial diseases had been referred to the Inherited Metabolic Diseases Laboratory at Cairo University Children’s Hospital. Laboratory investigations and analyses included histochemical staining of cytochrome c oxidase and succinate dehydrogenase in muscle biopsies, as well as spectrophotometric assays of RC complexes in muscle homogenates.
Results. Twenty-three patients (60.5%) were diagnosed with different RC enzyme deficiencies. Fifteen patients (65%) had complex I
deficiency and all of them also had lactic acidosis (mean (standard deviation)) plasma lactate concentration of 4 (1.65) mmol/L). Two
patients (9%) with marked complex IV deficiency both showed COX-negative ragged red fibers (RRFs) on histochemical staining.
Combined complex I and complex II deficiency with scattered COX-stain deficiency and RRFs was diagnosed in 2 patients (5.25%), while
a further 2 patients (5.26%) had combined (complex I, II+III, complex IV) deficiencies. Isolated complex II deficiency was diagnosed in
2 patients (5.26%) and 15 (39.5%) patients had normal RC enzyme activities.
Conclusion. Biochemical assay of RC complexes is considered the cornerstone for diagnosis of RC complex mitochondrial disorders.
These disorders are common among Egyptian paediatric patients.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 2012;7(6):1235-1246. https://doi.org/10.1038/nprot.2012.058
Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neuro 2015;77(5):753-759. https://doi.org/10.1002/ana.24362
Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT. Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 2006;3(1):9-13. https://doi.org/10.1016/j.cmet.2005.12.001
Chretien D, Rustin P, Bourgeron T, Rotig A, Saudubray JM, Munnich A. Reference charts for respiratory chain activities in human tissues. Clin Chim Acta 1994;228(1):53-70. https://doi.org/10.1016/0009-8981(94)90056-6
Yarham JW, Elson JL, Blakely EL, Mcfarland R, Taylor RW. Mitochondrial tRNA mutations and disease. Wiley Interdiscip Rev RNA 2010;1(2):304-324. https://doi. org/10.1002/wrna.27
Frazier AE, Thorburn DR, Compton AG. Mitochondrial energy generation disorders: Genes, mechanisms, and clues to pathology. J Biol Chem 2019;294(14):5386-5895. https://doi.org/10.1074/jbc.R117.809194
Sulaiman SA, Rani ZM, Radin FZM, M NAA. Advancement in the diagnosis of mitochondrial diseases. J Transl Gen Genomics 2020;4:159-187. https://doi. org/10.20517/jtgg.2020.27
Selim LA, Ghaffar HA, Hamdi MM, Hagras AM, Nakhla GA, Kamel AM. A clinicopathological and brain MRI study in Egyptian children with mitochondrial disorders. J Pediatr Neurol 2005;3(4):207-215. https://doi. org/10.1055/s-0035-1557283
Al-Ettribi GMM, Effat LK, El-Bassyouni HT, Zaki MS, Shanab G, Karim AM. Screening seven common mitochondrial mutations in 28 Egyptian patients with suspected mitochondrial disease. Middle East J Med Genet 2013;2(1):28-37. https://doi.org/10.1097/01.MXE.0000422779.05483.d7
Selim L, van Coster R, Mehaney D, et al. Mitochondrial neurogastrointestinal encephalopathy: Clinical, biochemical and molecular study in three Egyptian patients. Genet Couns 2016;27(2):193-205.
Al-Ettribi GMM, Effat LK, El-Bassyouni HT, Zaki MS, Shanab G, Karim AM. Clinical and molecular findings in eight Egyptian patients with suspected mitochondrial disorders and optic atrophy. Egypt J Med Hum Genet 2013;14(1):37-47. https://doi.org/10.1016/j.ejmhg.2012.08.002
Morava E, van den Heuvel L, Hol F, et al. Mitochondrial disease criteria: Diagnostic applications in children. Neurology 2006;67(10):1823-1826. https:// doi.org/10.1212/01.wnl.0000244435.27645.54
Thorburn DR. Practical problems in detecting abnormal mitochondrial function and genomes. Hum Reprod 2000;2(15):57-67. https://doi.org/10.1093/ humrep/15.suppl_2.57
El-Bassyouni HT, Abdallah HA, Shousha AS, Hassan Ibraheim WHI. Clinical and biochemical aspects of mitochondrial disorders in Egyptian patients. Int J Child Neuropsychiatry 2004;14(1):41-50.
Liang C, Ahmad K, Sue CM. The broadening spectrum of mitochondrial disease: Shifts in the diagnostic paradigm. Biochim Biophys Acta 2014;1840(4):1360- 1367. https://doi.org/10.1016/j.bbagen.2013
Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004;114(4):925- 931. https://doi.org/10.1542/peds.2004-0718
BernierFP,BonehA,DennettX,ChowCW,ClearyMA,ThorburnDR.Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59(9):1406-1411. https://doi.org/10.1212/01.wnl.0000033795.17156.00
Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17(9):689-701. https//doi.org/10.1038/gim.2014.177
Pronicka E, Piekutowska-Abramczuk D, Ciara E, et al. New perspective in diagnostics of mitochondrial disorders: Two years’ experience with whole-exome sequencing at a national paediatric centre. J Transl Med 2016;14(1):174. https:// doi.org/10.1186/s12967-016-0930-9
Fassone E, Rahman S. Complex I deficiency: Clinical features, biochemistry and molecular genetics. J Med Genet 2012;49(9):578-590. https://doi.org/10.1136/ jmedgenet-2012-101159
Lee S, Na JH, Lee YM. Epilepsy in Leigh syndrome with mitochondrial DNA mutations. Front Neurol 2019;10:496. https://doi.org/10.3389/fneur.2019.00496
Smuts I, Louw R, Du Toit H, Klopper B, Mienie LJ, Van Der Westhuizen FH. An overview of a cohort of South African patients with mitochondrial disorders. J Inherit Metab Dis 2010;33(Suppl 3):S95-S104. https://doi.org/10.1007∕ s10545- 0099031-8
MeldauS,OwenPE,KhanK,RiordanTG.Mitochondrialmoleculargeneticresults in a South African cohort: Divergent mitochondrial and nuclear DNA findings. J Clin Pathol 2022;75:34-38. https://doi.org/10.1136/jclinpath-2020-207026
Rollins S, Prayson RA, McMahon JT, Cohen BH. Diagnostic yield muscle biopsy in patients with clinical evidence of mitochondrial cytopathy. Am J Clin Pathol 2001;116(3):326-330. https//doi.org/10.1309/WATB-W4QV-NA53-B9MY
Sánchez-Caballero L, Ruzzenente B, Bianchi L, et al. Mutations in complex I assembly factor TMEM126B result in muscle weakness and isolated complex I deficiency. Am J Hum Genet 2016;99(1):208-216. https://doi.org/10.1016/j. ajhg.2016.05.022